Glenmede Trust’s Akcea Therapeutics Inc AKCA Stock Holding History

Glenmede Trust’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-68	Closed	-$1K	–	2563
2020 Q3	$1K	Hold	68	–	–	﹤0.01%	2442
2020 Q2	$0	Buy	+68	New	+$1.05K	﹤0.01%	2725

Glenmede Trust's AKCA Position: Q4 2020 in Review

Glenmede Trust sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 68 shares — an estimated $1K sold.

Glenmede Trust first reported a position in AKCA in Q2 2020 and held it in 2 quarters. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Glenmede Trust reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 68 Akcea Therapeutics Inc shares in Q4 2020, an estimated $1K.
Glenmede Trust first reported a position in Akcea Therapeutics Inc in Q2 2020 and held it in 2 quarters.
Glenmede Trust's Akcea Therapeutics Inc position peaked at $1K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.